Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 3
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status.
Lorenzo M, Jacobs-Cachá C, Palau P, Amiguet M, Seller J, Núñez E, Espriella R, Górriz JL, Miñana G, Sanchis J, Bayés-Genis A, Soler MJ, Packer M, Núñez J; DAPA-VO2 Investigators. Lorenzo M, et al. Among authors: amiguet m. JACC Heart Fail. 2023 Nov;11(11):1611-1622. doi: 10.1016/j.jchf.2023.07.010. Epub 2023 Sep 6. JACC Heart Fail. 2023. PMID: 37676213 Clinical Trial.
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial.
Palau P, Amiguet M, Domínguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gómez Doblas JJ, de la Espriella R, Miñana G, Mezcua AR, Santas E, Bodí V, Sanchis J, Pascual-Figal D, Górriz JL, Baýes-Genís A, Núñez J; DAPA-VO2 Investigators (see Appendix). Palau P, et al. Among authors: amiguet m. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35604416 Free article. Clinical Trial.
Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction.
Lorenzo M, Miñana G, Palau P, Amiguet M, Seller J, Garcia Pinilla JM, Domínguez E, Villar S, DE LA Espriella R, Núñez E, Górriz JL, Valle A, Bodí V, Sanchis J, Bayés-Genis A, Núñez J; DAPA-VO2 Investigators. Lorenzo M, et al. Among authors: amiguet m. J Card Fail. 2023 May;29(5):849-854. doi: 10.1016/j.cardfail.2023.02.008. Epub 2023 Mar 4. J Card Fail. 2023. PMID: 36871614 Clinical Trial.
Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction-a substudy of the DAPA-VO2 study.
Mora-Fernández C, Pérez A, Mollar A, Palau P, Amiguet M, de la Espriella R, Sanchis J, Górriz JL, Soler MJ, Navarro-González JF, Núñez J; DAPA-VO2 Investigators; DAPA-VO Investigators. Mora-Fernández C, et al. Among authors: amiguet m. Front Cardiovasc Med. 2023 Aug 25;10:1242108. doi: 10.3389/fcvm.2023.1242108. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745119 Free PMC article.
Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction.
Miñana G, de la Espriella R, Palau P, Amiguet M, Seller J, García Pinilla JM, Núñez E, Górriz JL, Valle A, Sanchis J, Bayés-Genís A, Núñez J; en representación de los investigadores del DAPA-VO2. Miñana G, et al. Among authors: amiguet m. Rev Esp Cardiol (Engl Ed). 2023 Oct;76(10):783-792. doi: 10.1016/j.rec.2023.03.007. Epub 2023 Mar 22. Rev Esp Cardiol (Engl Ed). 2023. PMID: 36958534 Clinical Trial. English, Spanish.
Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure.
de la Espriella R, Amiguet M, Miñana G, Rodríguez JC, Moyano P, Segarra D, Fernández J, Santas E, Núñez G, Lorenzo M, Bonanad C, Alania E, Valle A, Sanchis J, Bodí V, Górriz JL, Navarro J, Codina P, Voors AA, Bayés-Genís A, Núñez J. de la Espriella R, et al. Among authors: amiguet m. Eur J Heart Fail. 2022 Nov;24(11):2108-2117. doi: 10.1002/ejhf.2651. Epub 2022 Aug 29. Eur J Heart Fail. 2022. PMID: 36054502 Free article.
Iron deficiency and long-term mortality in elderly patients with acute coronary syndrome.
González-D'Gregorio J, Miñana G, Núñez J, Núñez E, Ruiz V, García-Blas S, Bonanad C, Mollar A, Valero E, Amiguet M, Sastre C, Sanchis J. González-D'Gregorio J, et al. Among authors: amiguet m. Biomark Med. 2018 Sep;12(9):987-999. doi: 10.2217/bmm-2018-0021. Epub 2018 Jul 25. Biomark Med. 2018. PMID: 30043644 Clinical Trial.
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial.
Núñez J, Miñana G, Cardells I, Palau P, Llàcer P, Fácila L, Almenar L, López-Lereu MP, Monmeneu JV, Amiguet M, González J, Serrano A, Montagud V, López-Vilella R, Valero E, García-Blas S, Bodí V, de la Espriella-Juan R, Lupón J, Navarro J, Górriz JL, Sanchis J, Chorro FJ, Comín-Colet J, Bayés-Genís A; Myocardial‐IRON Investigators* †. Núñez J, et al. Among authors: amiguet m. J Am Heart Assoc. 2020 Feb 18;9(4):e014254. doi: 10.1161/JAHA.119.014254. Epub 2020 Feb 13. J Am Heart Assoc. 2020. PMID: 32067585 Free PMC article. Clinical Trial.
Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.
Del Canto I, Santas E, Cardells I, Miñana G, Palau P, Llàcer P, Fácila L, López-Vilella R, Almenar L, Bodí V, López-Lereu MP, Monmeneu JV, Sanchis J, Moratal D, Maceira AM, de la Espriella R, Chorro FJ, Bayés-Genís A, Núñez J; Myocardial‐IRON Investigators †. Del Canto I, et al. J Am Heart Assoc. 2022 Apr 5;11(7):e022214. doi: 10.1161/JAHA.121.022214. Epub 2022 Mar 18. J Am Heart Assoc. 2022. PMID: 35301854 Free PMC article. Clinical Trial.
13 results